Cooley advised Poseida Therapeutics on the deal.Poseida Therapeutics, a clinical-stage biopharmaceutical company, announced its strategic collaboration and license agreement with Roche. The agreement will leverage Poseida’s novel…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
